Breathlessness on Immunotherapy — Infection, Pneumonitis or Progression?

New, worsening or unexplained breathlessness during immunotherapy can mean a chest infection, immune-related pneumonitis (inflammation of the lungs caused by your own immune system), or — less commonly — the cancer itself. These three cannot be told apart by symptoms alone, so oncology teams treat any new breathlessness as urgent until imaging and tests say otherwise.

Breathlessness during immunotherapy usually comes from one of three causes: a chest infection, immune-related pneumonitis (inflamed lung tissue from an overactive immune response), or the cancer affecting the lungs or airway. All three can look identical from the outside, which is why a scan and clinical assessment — not guesswork — decide the cause.

Your oncology team distinguishes the three using a chest CT scan, an oxygen level check and blood tests, and sometimes a sputum or blood test for infection. Pneumonitis shows a distinct "ground-glass" pattern on CT and does not respond to antibiotics; infection usually does. Progression shows growing tumour on imaging rather than a diffuse inflammation pattern.

Because the three causes need different treatments — antibiotics, steroids, or an oncology review of the treatment plan — the distinguishing tests matter more than trying to guess the cause from how the breathlessness feels.

Breathlessness is urgent because immune pneumonitis can progress from mild to severe within days, and neither infection nor progression should be assumed without checking. Because home remedies cannot treat inflamed lung tissue, an infection, or tumour growth, the safe response to any new breathlessness is prompt medical assessment — not rest, breathing exercises, or waiting to see if it passes.

If you are ever unsure whether your breathlessness counts as "new" or "worse", treat it as urgent and call. A same-day assessment that turns out to be reassuring costs far less than a delayed one that doesn't.

Reporting breathlessness early leads to a structured pathway, not guesswork — infection is checked for, imaging looks for pneumonitis or progression, and treatment starts based on what's actually found. See our companion page, How Immune Pneumonitis Is Diagnosed, for the full clinical picture.

1. 1

   Same-day review and oxygen check

   Your clinician checks your oxygen saturation and breathing rate and grades severity using standard oncology criteria.

2. 2

   Chest CT scan

   A CT scan looks for the "ground-glass" pattern typical of pneumonitis, signs of infection, or new/growing tumour involvement.

3. 3

   Ruling out infection

   Blood tests and sometimes a sputum or blood culture are sent, since a bacterial or viral cause needs antibiotics rather than steroids.

4. 4

   Pulmonology opinion if pneumonitis is suspected

   A lung specialist is brought in alongside your oncology team to confirm the diagnosis and guide steroid dosing.

5. 5

   Treatment and a decision on your immunotherapy plan

   Depending on the cause, treatment may be antibiotics, steroids with a temporary treatment pause, or a tumour board review of your overall plan. Our page on Treatment for Immune Pneumonitis and How Long Recovery Takes explains what recovery typically looks like.

These companion pages go deeper into specific parts of the same lung irAE pathway — worth bookmarking alongside this one.

• How Immune Pneumonitis Is Diagnosed — the full imaging and testing pathway behind the confirmation steps above.
• Treatment for Immune Pneumonitis and How Long Recovery Takes — what steroid treatment and a treatment pause typically involve.
• Immunotherapy When You Already Have COPD or Fibrosis — how monitoring changes if you already have a lung condition.
• Immunotherapy at CION Cancer Clinics — how we monitor and support patients through immune-related side effects, from the first infusion onward.

Immune Reactions Are Manageable When Caught Early

Patients who report breathing symptoms promptly are supported by the same multidisciplinary team throughout treatment.